Status:
UNKNOWN
RGD-K5 in Head and Neck Cancer Patients
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Head and Neck Neoplasms
Eligibility:
All Genders
20+ years
Brief Summary
1. Primary endpoint(s): To determine the relationship between the drug distribution and angiogenesis in head and neck cancer patients. 2. Secondary endpoint(s): To expand the safety database of \[F-18...
Detailed Description
This is an uncontrolled, open-labeled, non-randomized, prospective study. The study duration is expected to be completed in a period of 3 year. Up to 100 patients would be included. Group A would be t...
Eligibility Criteria
Inclusion
- Head and neck cancer patients (including nasopharyngeal cancer)
- Age equals or more than 20 years old
- Referred by Chang Gung Memorial Hospital (CGMH) Head and Neck Oncology team.
- Willing to sign the informed consent
Exclusion
- Patient who is pregnant or lactating;
- Patients with a concomitant or previous 2nd primary cancer other than head and neck malignancy;
- Unable to tolerate MR or PET/CT scan, such as those with magnetic implants (e.g. those received intracranial aneurysm surgery, cardiac pacemaker, artificial valves replacement, artificial ears), poor blood sugar control (fasting sugar more than 200 mg/dl), claustrophobia, unable to lie still.
- Unable to give informed consent
Key Trial Info
Start Date :
June 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2014
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01447134
Start Date
June 1 2011
End Date
June 1 2014
Last Update
October 6 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.